One of the best characterized immune checkpoints, and one of two unequivocally shown to operate in cancer cells, involves the interaction between programmed cell death-1 (PDCD1, often known as PD1) on the T cell and its ligand (CD274, often known as PD-L1). The gene discussed is CD274; the disease is cancer.